Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Local production of chemokines and prostaglandin E2 in the acute, chronic and recovery phase of murine experimental colitis.

Melgar S, Drmotova M, Rehnström E, Jansson L, Michaëlsson E.

Cytokine. 2006 Sep;35(5-6):275-83. Epub 2006 Nov 7.

PMID:
17088072
2.

Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation.

Melgar S, Karlsson A, Michaëlsson E.

Am J Physiol Gastrointest Liver Physiol. 2005 Jun;288(6):G1328-38. Epub 2005 Jan 6.

3.

Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters.

Karlsson A, Jägervall A, Pettersson M, Andersson AK, Gillberg PG, Melgar S.

Int Immunopharmacol. 2008 Jan;8(1):20-7. Epub 2007 Oct 29.

PMID:
18068096
4.

Dextran sulfate sodium-induced colitis generates a transient thymic involution--impact on thymocyte subsets.

Fritsch Fredin M, Elgbratt K, Svensson D, Jansson L, Melgar S, Hultgren Hörnquist E.

Scand J Immunol. 2007 May;65(5):421-9.

6.

Lactobacillus casei secreting alpha-MSH induces the therapeutic effect on DSS-induced acute colitis in Balb/c Mice.

Yoon SW, Lee CH, Kim JY, Kim JY, Sung MH, Poo H.

J Microbiol Biotechnol. 2008 Dec;18(12):1975-83.

7.

Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease.

Melgar S, Karlsson L, Rehnström E, Karlsson A, Utkovic H, Jansson L, Michaëlsson E.

Int Immunopharmacol. 2008 Jun;8(6):836-44. doi: 10.1016/j.intimp.2008.01.036. Epub 2008 Mar 7.

PMID:
18442787
8.

The role of dendritic cells in the development of acute dextran sulfate sodium colitis.

Berndt BE, Zhang M, Chen GH, Huffnagle GB, Kao JY.

J Immunol. 2007 Nov 1;179(9):6255-62.

9.

CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.

Maharshak N, Hart G, Ron E, Zelman E, Sagiv A, Arber N, Brazowski E, Margalit R, Elinav E, Shachar I.

Inflamm Bowel Dis. 2010 Sep;16(9):1496-504. doi: 10.1002/ibd.21254.

PMID:
20222120
10.

Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.

Mikami S, Nakase H, Yamamoto S, Takeda Y, Yoshino T, Kasahara K, Ueno S, Uza N, Oishi S, Fujii N, Nagasawa T, Chiba T.

J Pharmacol Exp Ther. 2008 Nov;327(2):383-92. doi: 10.1124/jpet.108.141085. Epub 2008 Aug 20.

11.

The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation.

Xu Y, Hunt NH, Bao S.

Cell Res. 2008 Dec;18(12):1220-9. doi: 10.1038/cr.2008.310.

PMID:
19030026
12.

PACAP provides colonic protection against dextran sodium sulfate induced colitis.

Azuma YT, Hagi K, Shintani N, Kuwamura M, Nakajima H, Hashimoto H, Baba A, Takeuchi T.

J Cell Physiol. 2008 Jul;216(1):111-9. doi: 10.1002/jcp.21381.

PMID:
18205183
13.

Involvement of CPI-17 downregulation in the dysmotility of the colon from dextran sodium sulphate-induced experimental colitis in a mouse model.

Sato K, Ohkura S, Kitahara Y, Ohama T, Hori M, Sato M, Kobayashi S, Sasaki Y, Hayashi T, Nasu T, Ozaki H.

Neurogastroenterol Motil. 2007 Jun;19(6):504-14.

PMID:
17564632
14.

Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis.

Khor TO, Huang MT, Kwon KH, Chan JY, Reddy BS, Kong AN.

Cancer Res. 2006 Dec 15;66(24):11580-4.

15.

Chemokines involved in protection from colitis by CD4+CD25+ regulatory T cells.

Kristensen NN, Brudzewsky D, Gad M, Claesson MH.

Inflamm Bowel Dis. 2006 Jul;12(7):612-8.

PMID:
16804399
16.

Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis.

Gonzalez-Rey E, Anderson P, González MA, Rico L, Büscher D, Delgado M.

Gut. 2009 Jul;58(7):929-39. doi: 10.1136/gut.2008.168534. Epub 2009 Jan 9.

PMID:
19136511
17.

Reactivation of inflammatory bowel disease in a mouse model of depression.

Ghia JE, Blennerhassett P, Deng Y, Verdu EF, Khan WI, Collins SM.

Gastroenterology. 2009 Jun;136(7):2280-2288.e1-4. doi: 10.1053/j.gastro.2009.02.069. Epub 2009 Mar 9.

PMID:
19272381
18.

In vivo treatment with a nonapeptide thymic hormone, facteur thymique serique (FTS), ameliorates chronic colitis induced by dextran sulphate sodium in mice.

Sun X, Yamada H, Yoshihara K, Awaya A, Yoshikai Y.

Int Immunopharmacol. 2007 Jul;7(7):928-36. Epub 2007 Mar 28.

PMID:
17499195
19.

Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice.

Ito R, Kita M, Shin-Ya M, Kishida T, Urano A, Takada R, Sakagami J, Imanishi J, Iwakura Y, Okanoue T, Yoshikawa T, Kataoka K, Mazda O.

Biochem Biophys Res Commun. 2008 Dec 5;377(1):12-6. doi: 10.1016/j.bbrc.2008.09.019. Epub 2008 Sep 15.

PMID:
18796297
20.

UR-1505, a salicylate able to selectively block T-cell activation, shows intestinal anti-inflammatory activity in the chronic phase of the DSS model of rat colitis.

Bailón E, Comalada M, Román J, Michelena P, Ramis I, Merlos M, Nieto A, Concha A, Zarzuelo A, Gálvez J.

Inflamm Bowel Dis. 2008 Jul;14(7):888-97. doi: 10.1002/ibd.20381.

PMID:
18253952

Supplemental Content

Support Center